Article
A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
PloS one - 1 Jan 2016
Flisiak Robert, Shiffman Mitchell, Arenas Juan, Cheinquer Hugo, Nikitin Igor, Dong Yuping, Rana Khurram, Srinivasan Subasree
Abstract excerpt
BACKGROUND: A randomized, double-blind, multinational, phase 3 study was conducted comparing the efficacy and safety of peginterferon lambda-1a (Lambda)/ribavirin (RBV)/telaprevir (TVR) vs. peginterferon alfa-2a (Alfa)/RBV/TVR in patients with chronic hepatitis C virus (HCV) genotype-1 (GT-1) infection. METHODS: Patients (treatment-naïve or relapsers on prior Alfa/RBV treatment) were randomly assigned in a 2:1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.